arrow
R

Ronan Flippot

gustave roussy
H指数:26
被引数:2,790

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Immune checkpoint inhibitors in advanced upper-tract urothelial carcinoma: a multicenter study

免疫检查点抑制剂在晚期上尿路尿路上皮癌中的应用:一项多中心研究

2026-09-150
OAAI
30 Myeloid- Versus Effector-Driven Circulating Immune States Define Treatment-Specific Benefit in Metastatic Clear Cell Renal Cell Carcinoma

30 髓系与效应驱动的循环免疫状态定义了转移性透明细胞肾细胞癌的治疗特异性获益

2026-09-020
OAAI
58 Baseline Peripheral TCR Diversity as a Biomarker of Response to First-line Immunotherapy in Metastatic Clear Cell Renal Cell Carcinoma

基线外周TCR多样性作为转移性透明细胞肾细胞癌一线免疫治疗反应的生物标志物

2026-09-020
OAAI
Risk stratification and conditional recurrence after radical cystectomy: toward adaptive follow-up

风险分层和根治性膀胱切除术后的条件性复发:迈向适应性随访

2026-03-120
PRE
Nivolumab in Metastatic Clear-cell Renal Cell Carcinoma: An Integrative Biomarker Analysis from the NIVOREN GETUG-AFU 26 Phase 2 Study

转移性透明细胞肾细胞癌中的Nivolumab: 来自NIVOREN getug-afu 26 2期研究的综合生物标志物分析

2025-11-110
PRE
The actionable microbial gut checkpoint MAdCAM-1 in patients with advanced renal cell carcinoma

晚期肾细胞癌患者中可操作性的微生物肠道检查点MAdCAM-1

2025-10-010
OA
Summary Intercontinental Multidisciplinary Oncology Videoconferencing between the South Pacific and the French mainland: Reasons for medical evacuation after more than 2000 cases of cancers discussed

摘要:南太平洋与法国本土之间的洲际多学科肿瘤学视频会议:讨论超过2000例癌症病例后的医疗转运原因

2025-09-010
PRE
Activity of Lutetium-177 Prostate-specific Membrane Antigen and Determinants of Outcomes in Patients with Metastatic Castration- resistant Prostate Cancer Previously Treated with Cabazitaxel: The PACAP Study

先前接受卡巴他赛治疗的转移性去势抵抗性前列腺癌患者的177前列腺特异性膜抗原活性和预后决定因素: PACAP研究

2024-10-010
OA
Microbiota-related multiomics to assess the clinical relevance of antibiotics (ATB) in immunotherapy (ICI)

微生物组相关多组学评估抗生素(ATB)在免疫治疗(ICI)中的临床相关性

2024-09-011
PRE
CARE1 pragmatic clinical trial: First line randomised study platform to optimize treatment in patients with metastatic renal cell carcinoma

CARE1实用性临床试验:针对转移性肾细胞癌患者优化治疗的一线随机研究平台

2024-09-013
PRE
Metastatic renal cell carcinoma with occult primary: a multicenter prospective cohort
2024-07-180
OAAI
Development of Novel Models of Aggressive Variants of Castration-resistant Prostate Cancer

去势抵抗性前列腺癌侵袭性变异体新模型的建立

2024-06-011
PRE
Safety and efficacy of nivolumab in elderly patients with metastatic clear cell renal cell carcinoma: Analysis of the NIVOREN GETUG-AFU 26 study
2024-04-011
PRE
Metastatic renal cell carcinoma with occult primary: Clinical and biological evidence for a new entity of cancers of unknown primary that beneficiates from tissue-tailored treatment
2024-03-220
PRE